Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Pharmaceutical Industry Association

Executive Summary

Chairman William Haddad announces Nov. 3 that he will resign as chairman, effective Dec. 31. Haddad will remain on GPIA's board and continue to chair its international committee. Currently chairman of MIR Pharmaceutical, Haddad says he is working with partners in Israel, Holland and the U.S. to establish a generic drug industry in the former Soviet Union. Haddad had been with GPIA since its founding in 1981, serving as its first president.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023555

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel